plicamycin has been researched along with Cancer of Gastrointestinal Tract in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boichuk, S; Brown, MF; Cuevas, R; Debiec-Rychter, M; Duensing, A; Korzeniewski, N; Kuan, SF; Lee, DJ; Makielski, KR; Mehalek, KR; Parry, JA; Schöffski, P; Seneviratne, DS; Taguchi, T; Wozniak, A; Zewe, J | 1 |
| Thorne, J | 1 |
2 other study(ies) available for plicamycin and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Unbiased compound screening identifies unexpected drug sensitivities and novel treatment options for gastrointestinal stromal tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Drug Screening Assays, Antitumor; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Mice; Mice, Nude; Mitoxantrone; Plicamycin; Topoisomerase II Inhibitors; Transcription, Genetic; Tumor Cells, Cultured | 2014 |
Drug repurposing identifies therapeutic agents for gastrointestinal stromal tumors.
Topics: Antineoplastic Agents; Drug Discovery; Drug Repositioning; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gastrointestinal Tract; Humans; Mitoxantrone; Plicamycin; Protein Synthesis Inhibitors; Sp1 Transcription Factor; Topoisomerase II Inhibitors | 2014 |